Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Finished Goods (2021 - 2025)

Historic Finished Goods for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $22221.0.

  • HeartSciences' Finished Goods fell 159.43% to $22221.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $22221.0, marking a year-over-year decrease of 159.43%. This contributed to the annual value of $44069.0 for FY2025, which is 9515.96% up from last year.
  • As of Q4 2025, HeartSciences' Finished Goods stood at $22221.0, which was down 159.43% from $44069.0 recorded in Q3 2025.
  • HeartSciences' 5-year Finished Goods high stood at $296365.0 for Q2 2021, and its period low was $22221.0 during Q4 2025.
  • Its 5-year average for Finished Goods is $45396.7, with a median of $28662.0 in 2022.
  • As far as peak fluctuations go, HeartSciences' Finished Goods crashed by 9032.88% in 2022, and later surged by 9515.96% in 2025.
  • HeartSciences' Finished Goods (Quarter) stood at $296365.0 in 2021, then plummeted by 90.33% to $28663.0 in 2022, then fell by 0.0% to $28662.0 in 2023, then fell by 21.22% to $22581.0 in 2024, then fell by 1.59% to $22221.0 in 2025.
  • Its Finished Goods stands at $22221.0 for Q4 2025, versus $44069.0 for Q3 2025 and $44069.0 for Q2 2025.